168 related articles for article (PubMed ID: 15714932)
1. Palliative radiotherapy for non-small-cell lung cancer: which dose?
Hoskin PJ
Clin Oncol (R Coll Radiol); 2005 Feb; 17(1):59-60. PubMed ID: 15714932
[No Abstract] [Full Text] [Related]
2. Radiation therapy for non-small cell lung cancer (NSCLC).
Choy H; Chakravarthy A; Kim JS
Cancer Treat Res; 2001; 105():121-48. PubMed ID: 11224985
[No Abstract] [Full Text] [Related]
3. A palliative accelerated irradiation regimen for advanced non-small-cell lung cancer vs. conventionally fractionated 60 Gy: results of a randomized equivalence study: regarding Nestle et al. IJROBP 2000; 48:95-103.
Byhardt R; Scott C
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):837. PubMed ID: 11417531
[No Abstract] [Full Text] [Related]
4. Hypofractionated radiotherapy for advanced non-small-cell lung cancer: is the LINAC half full?
Bogart JA
J Clin Oncol; 2004 Mar; 22(5):765-8. PubMed ID: 14990629
[No Abstract] [Full Text] [Related]
5. [A palliative accelerated irradiation regimen for advanced non-small-cell lung cancer versus conventionally fractionated 60 Gy: results of a randomized equivalence study].
Zagamé L; Noël G; Mazeron JJ
Cancer Radiother; 2001 Apr; 5(2):199. PubMed ID: 11355587
[No Abstract] [Full Text] [Related]
6. No consensus on the optimal palliative radiotherapy regimen for people with inoperable non-small-cell lung cancer.
Baldini E
Cancer Treat Rev; 2003 Oct; 29(5):445-7. PubMed ID: 12972363
[No Abstract] [Full Text] [Related]
7. Radiotherapy with curative intent for lung cancer: a continuing success story.
De Ruysscher D; van Elmpt W; Lambin P
Radiother Oncol; 2011 Nov; 101(2):237-9. PubMed ID: 22079528
[No Abstract] [Full Text] [Related]
8. Symptom control and quality of life in people with lung cancer: a randomised trial of two palliative radiotherapy fractionation schedules.
Erridge SC; Gaze MN; Price A; Kelly CG; Kerr GR; Cull A; MacDougall RH; Howard GC; Cowie VJ; Gregor A
Clin Oncol (R Coll Radiol); 2005 Feb; 17(1):61-7. PubMed ID: 15714933
[TBL] [Abstract][Full Text] [Related]
9. Updated data for chart in NSCLC: a missed opportunity.
Rowell NP
Radiother Oncol; 2000 Apr; 55(1):85-7. PubMed ID: 10885970
[No Abstract] [Full Text] [Related]
10. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S
J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635
[TBL] [Abstract][Full Text] [Related]
11. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
van den Hout WB; Kramer GW; Noordijk EM; Leer JW
J Natl Cancer Inst; 2006 Dec; 98(24):1786-94. PubMed ID: 17179480
[TBL] [Abstract][Full Text] [Related]
12. Stage III nonsmall cell lung cancer: still a challenge for the radiation oncologist.
Van Houtte P
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):533-5. PubMed ID: 9336128
[No Abstract] [Full Text] [Related]
13. Non-aggressive, non-surgical treatment of inoperable non-small cell lung cancer (NSCLC). American College of Radiology. ACR Appropriateness Criteria.
Graham MV; Byhardt RW; Sause WT; Curran WJ; Fuller D; Ko B; Komaki R; Weisenburger TH; Kaiser LR; Leibel SA
Radiology; 2000 Jun; 215 Suppl():1347-62. PubMed ID: 11037551
[No Abstract] [Full Text] [Related]
14. Split-course and palliative radiation therapy in non-small cell lung cancer.
Montebello JF
Indiana Med; 1987 Oct; 80(10):921-4. PubMed ID: 2449489
[No Abstract] [Full Text] [Related]
15. Radiotherapy for inoperable lung cancer.
Timothy AR; Girling DJ; Saunders MI; Macbeth F; Hoskin PJ;
Clin Oncol (R Coll Radiol); 2001; 13(2):86-7. PubMed ID: 11373884
[No Abstract] [Full Text] [Related]
16. The role of radiotherapy and the value of combined treatment in lung cancer.
Van Houtte P
Eur J Cancer; 2001 Oct; 37 Suppl 7():S91-8. PubMed ID: 11888009
[No Abstract] [Full Text] [Related]
17. Prophylactic cranial irradiation in high-risk non-small cell lung cancer patients.
Arriagada R; Le Péchoux C; Baeza MR
Lung Cancer; 2003 Dec; 42 Suppl 2():S41-5. PubMed ID: 14644535
[No Abstract] [Full Text] [Related]
18. Cancer Trials Ireland (ICORG) 06-34: A multi-centre clinical trial using three-dimensional conformal radiation therapy to reduce the toxicity of palliative radiation for lung cancer.
McDermott RL; Armstrong JG; Thirion P; Dunne M; Finn M; Small C; Byrne M; O'Shea C; O'Sullivan L; Shannon A; Kelly E; Hacking DJ
Radiother Oncol; 2018 May; 127(2):253-258. PubMed ID: 29548561
[TBL] [Abstract][Full Text] [Related]
19. Postoperative radiotherapy in resected non-small-cell lung cancer: every creek has two banks.
Johnson DH; Turrisi A
Curr Oncol Rep; 2000 Jan; 2(1):51-3. PubMed ID: 11122824
[No Abstract] [Full Text] [Related]
20. Palliative percutaneous radiotherapy in non-small-cell lung cancer.
Budach W; Belka C
Lung Cancer; 2004 Aug; 45 Suppl 2():S239-45. PubMed ID: 15552805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
